Insilico Medicine, a developer of artificial intelligence tools for drug discovery, has mapped out its process for making an experimental drug for idiopathic pulmonary fibrosis (IPF). In a paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results